Work

Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells

Year: 2014

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-014-1561-8

Authors: Akemi Kosaka, Takayuki Ohkuri, Hideho Okada

Institutions: UPMC Hillman Cancer Center, University of Pittsburgh

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Directing Tumor-specific T cells to Tumors, Cancer Center Support Grant, Novel Immunotherapy of Glioma using miR-17-92 Transfected T Cells

OpenAlex ID: W2073880277

FWCI: 2.658

Cites: 51

Cited by: 110

Related to: 10